Why PTC Therapeutics Is Soaring Again
IMAGE SOURCE: GETTY IMAGES. What happened Investors in PTC Therapeutics (NASDAQ:PTCT), a biotech focused on rare diseases, are having a pleasant start to the trading week. Shares are up by 10% as of 10:45 a.m. EST on Monday. So what Shareholders can thank analysts at Credit Suisse for the company’s surging stock price. Credit Suisse upgraded the […]Read More